Phathom Pharmaceuticals (NASDAQ:PHAT) Receives Buy Rating fr

Phathom Pharmaceuticals (NASDAQ:PHAT) Receives Buy Rating from Needham & Company LLC

Phathom Pharmaceuticals (NASDAQ:PHAT) Receives Buy Rating from Needham & Company LLC

wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Ohio , United States , Canada , China , Molly Henderson , Stifel Nicolaus , Terrie Curran , Zurcher Kantonalbank Zurich Cantonalbank , Phathom Pharmaceuticals , Klingman Associates , Institutional Trading Of Phathom Pharmaceuticals , Securities Exchange Commission , Needham Company , China Universal Asset Management Co , Phathom Pharmaceuticals Inc , News Ratings For Phathom Pharmaceuticals Daily , Phathom Pharmaceuticals Company Profile , Phathom Pharmaceuticals Stock Performance , Get Free Report , Exchange Commission , Universal Asset Management , Kantonalbank Zurich Cantonalbank , Employees Retirement System , Phathom Pharmaceuticals Daily ,